Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study - Al-Sawaf, Othman; Robrecht, Sandra; Zhang, Can; Olivieri, Stefano; Chang, Yi Meng; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl-Anton; Sivchev, Liliya; Niemann, Carsten Utoft; et al. (Blood, 2024)